Annual Report

Overview

The report highlights Rua Bioscience's FY24 shift toward genetics and distribution, including first Australian revenues, expanded European distribution, and new product approvals in New Zealand. It describes expanded Compassionate Access Programme capacity to support up to 52 patients per month, alongside scholarships, student exposure, and internship initiatives in Tairawhiti. On sustainability, the company reports 255 tCO2-e of FY24 emissions, including newly measured Purchased Goods and Services, while stating that reduction targets will be set during FY25.

Document

Report type: Annual Report
Class: Financial
Scope: Full report
Fiscal year: 2024
Period: Ends 30 June 2024
Publication date: 30 September 2024
Language: English
Pages
File size
Restatement: Disclosed

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services